China Medical Technologies Reports FY2008 Fourth Fiscal Quarter and Full Year Unaudited Financi...(44178 79641 Accumulated other ...),Health

Date:9/1/2009

44,178 79,641 Accumulated other comprehensive loss (48,046) (52,766) (51,946) (7,602) Retained earnings(1)(2) 819,070 932,161 988,435 144,658 Total shareholders' 1,522,761 1,667,392 1,738,405 254,417 equity Total liabilities and shareholders' equity 2,931,804 6,271,777 5,783,176 846,372 Notes: (1) The Company has performed a preliminary purchase price allocation after the completion of the SPR acquisition in December 2008. The Company will finalize the purchase price allocation as soon as practicable. (2) Due to the subsequent event described in the section "Recent Development on the Sale of the HIFU Business" above, a portion of the gain on disposal from HIFU business was deferred in accordance with GAAP based on the Company's estimate of maximum compensation. China Medical Technologies, Inc. Unaudited Condensed Consolidated Statements of Income For the Three Months Ended March 31, December 31, March 31, 2008 2008 2009 RMB RMB RMB US$ As adjusted(2) (in thousands except for per ADS information) Revenues, net(1) 181,048 225,296 248,635 36,388 Cost of revenues (74,886) (55,818) (60,206) (8,811) Gross profit 106,162 169,478 188,429 27,577 Operating expenses: Research and development (6,262) (8,304) (10,670) (1,562) Acquired in-process research and development(3) (672) (244,872) -- -- Sales and ma
'/>"/>

SOURCE China Medical Technologies, Inc. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
Related medicine news :

1. Chinas 1-child policy could backfire on its elderly
2. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
3. Expanding Prevalent Population Will Drive Dramatic Growth for the Asthma Drug Market in China
4. Bridgetech Announces Addition of the Agency for Healthcare Research and Quality as Content Provider in its Development of a Healthcare Web Portal in China
5. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
6. China Bionanometer Industries Corporation Promotes New Cosmetics Product Line in China
7. China Shenghuo Pharmaceutical Holdings, Inc. Begins Full-Scale Launch of 12Ways(R) Chinese Herbal Skin Care Product Line
8. Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety
9. Supplier Assessments to Help Buyers Identify Reliable China Exporters
10. Study shows lead-based paint problem isnt isolated to China
11. Bracco Announces Initiative to Save Children in China at 2007 Annual Meeting of CGI